SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-23-124715
Filing Date
2023-12-08
Accepted
2023-12-08 16:17:47
Documents
1
Group Members
VENROCK OPPORTUNITIES MANAGEMENT, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G tm2332269d1_sc13g.htm SC 13G 65329
  Complete submission text file 0001104659-23-124715.txt   67196
Mailing Address 221 CRESCENT STREET BLDG. 17, SUITE 401 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BLDG. 17, SUITE 401 WALTHAM MA 02453 617.272.4600
Viridian Therapeutics, Inc.\DE (Subject) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88625 | Film No.: 231475635
SIC: 8071 Services-Medical Laboratories

Mailing Address 3340 HILLVIEW AVENUE PALO ALTO CA 94304
Business Address 3340 HILLVIEW AVENUE PALO ALTO CA 94304 (650) 561-9580
Venrock Opportunities Fund, L.P. (Filed by) CIK: 0001855405 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G